Anumana develops AI-driven ECG algorithms for early cardiovascular diagnosis and care.
Anumana's investors include Boston Scientific, Matrix, NTT Venture Capital, nference, MedTech Innovator.
Anumana is headquartered in Cambridge, United States.
Anumana develops AI-driven ECG algorithms for early cardiovascular diagnosis and care.
Anumana is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anumana — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/anumana. Accessed August 14, 2026.
VCBacked. (2025). Anumana — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/anumana
{{cite web |title=Anumana — Funding & Investors |url=https://www.vcbacked.co/company/anumana |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated